Literature DB >> 8338291

Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia-like body.

B A Connor1, D R Shlim, J V Scholes, J L Rayburn, J Reidy, R Rajah.   

Abstract

OBJECTIVE: To confirm a suspected small-bowel injury in patients with a syndrome of protracted diarrhea associated with a coccidia-like body (CLB).
DESIGN: Investigation of an epidemic including a case-control study.
SETTING: Outpatient clinic in Kathmandu serving primarily the tourist and expatriate community in Nepal. PATIENTS: Nine patients with diarrhea with at least one stool specimen that was positive for the presence of a CLB and seven noninfected volunteer controls. MEASUREMENTS: Clinical data, microscopic examination of stool, bacteriologic and viral studies on submitted stool specimens, upper gastrointestinal endoscopy including duodenal aspiration and microscopy, small-bowel biopsy with subsequent light and electron microscopy.
RESULTS: Endoscopic evidence of inflammation of the distal duodenum was present in five of nine patients with CLB and in none of the seven controls. All nine patients with CLB were noted to have histologic evidence of small-bowel injury, which included acute and chronic inflammation, surface epithelial disarray, and varying degrees of villous atrophy and crypt hyperplasia. One of the seven controls had similar pathologic findings and developed CLB-related diarrhea 5 days later. The other controls had normal distal duodenal histologic results. The organism was found in two of nine duodenal aspirates but was not present in the preserved biopsy specimens as determined by light or electron microscopy.
CONCLUSIONS: The pathologic basis of CLB-associated diarrhea appears to be small-bowel injury whose cause remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338291     DOI: 10.7326/0003-4819-119-5-199309010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  Cyclosporiasis: an update.

Authors:  Cirle Alcantara Warren
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

2.  Uniform staining of Cyclospora oocysts in fecal smears by a modified safranin technique with microwave heating.

Authors:  G S Visvesvara; H Moura; E Kovacs-Nace; S Wallace; M L Eberhard
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  'Tropical sprue': some early investigators favoured an infective cause, but was a coccidian protozoan involved?

Authors:  G C Cook
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

4.  Diarrhea in the returned traveler.

Authors:  J W Sanders; D R Tribble
Journal:  Curr Gastroenterol Rep       Date:  2001-08

Review 5.  Persisting diarrhoea and malabsorption.

Authors:  G C Cook
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

6.  Prevalence of Cyclospora species and other enteric pathogens among children less than 5 years of age in Nepal.

Authors:  C W Hoge; P Echeverria; R Rajah; J Jacobs; S Malthouse; E Chapman; L M Jimenez; D R Shlim
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Parasites in patients with malabsorption syndrome: a clinical study in children and adults.

Authors:  Bijayini Behera; B R Mirdha; Govind K Makharia; Shinjini Bhatnagar; Siddhartha Dattagupta; J C Samantaray
Journal:  Dig Dis Sci       Date:  2007-08-31       Impact factor: 3.199

8.  Chronic diarrhea in travelers.

Authors:  Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

9.  Reiter syndrome following protracted symptoms of Cyclospora infection.

Authors:  B A Connor; E J Johnson; R Soave
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

10.  Epidemiologic studies of Cyclospora cayetanensis in Guatemala.

Authors:  C Bern; B Hernandez; M B Lopez; M J Arrowood; M A de Mejia; A M de Merida; A W Hightower; L Venczel; B L Herwaldt; R E Klein
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.